Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8438591 | EBioMedicine | 2017 | 11 Pages |
Abstract
While Fc glycosylation profiles have been associated with clinically manifest autoimmune diseases, in the present study we show that low galactosylation and sialyation in total IgG1 but not PR3-ANCA IgG1 predicts disease reactivation in patients with GPA who experience an ANCA rise during follow-up. We postulate that glycosylation profiles may be useful in pre-emptive therapy studies using ANCA rises as guideline.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Michael J. Kemna, Rosina Plomp, Pieter van Paassen, Carolien A.M. Koeleman, Bas C. Jansen, Jan G.M.C. Damoiseaux, Jan Willem Cohen Tervaert, Manfred Wuhrer,